Cobham has received a contract from Korean Aerospace Industries Ltd (KAI) to design and supply a pilot Oxygen System for the future KF-X, an advanced multirole fighter aircraft currently under development. This represents the fourth contract award Cobham has earned from KAI in support of the KF-X program. Other Cobham solutions selected by KAI for KF-X include Missile Ejection Launchers (MEL), a full range of Communication, Navigation and Identification (CNI) conformal antennas, and external fuel tanks and pylons.
Cobham Mission Systems, the market leader in military life support oxygen systems, will be leveraging its latest Next Generation Oxygen Concentrator technology, as well as the newly developed Electronic Seat Mounted Regulator to outfit the KF-X aircraft. This high-reliability system will not only meet or exceed the current requirements, but will be capable of spiral upgrades as new technologies, such as pilot breathing sensors, are introduced in the future.
“Cobham has a long history of working with KAI on a number of aircraft platforms. We are very excited that KAI selected Cobham’s latest oxygen concentrator solution for its newest platform,” said Kevin McKeown, Vice President, and General Manager of Cobham Mission Systems. “The KF-X program is strategically important for Cobham and this contract award will allow us to continue to lead the market in life support oxygen systems for military aircraft”, he added.
The multi-year contract will support the entire EMD Phase of KF-X aircraft development.
Cobham offers an innovative range of technologies and services to solve challenging problems in commercial, defence and security markets, from deep space to the depths of the ocean. We employ around 11,000 people primarily in the USA, UK, Europe and Australia, and have customers and partners in over 100 countries, with market-leading positions.